Artificial Intelligence (AI) In Predictive Toxicology Market Trends And Growth Drivers Point To Strong Future Potential
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Artificial Intelligence (AI) In Predictive Toxicology Market Forecast Highlighting Growth From $0.82 Billion To $2.29 Billion
The market for artificial intelligence in predictive toxicology has seen rapid expansion in recent years, with its value projected to rise from $0.64 billion in 2025 to $0.83 billion in 2026, reflecting a compound annual growth rate (CAGR) of 29.3%. Historical growth was driven by several factors, including a heightened demand for safer chemicals, intensified research and development efforts in pharmaceuticals, stricter regulatory requirements concerning chemical safety, early moves toward computational toxicology, and progress in bioinformatics tools.
In the market for artificial intelligence within predictive toxicology, substantial growth is anticipated over the coming years, with projections indicating it will reach a value of $2.29 billion by 2030, reflecting a compound annual growth rate of 28.9%. This expansion in the forecast period is driven by factors such as the greater uptake of AI-powered predictive models, the proliferation of cloud-based toxicology platforms, the merging of genomic and chemical data sources, heightened partnerships among pharmaceutical and biotechnology entities, and an escalating need for swift chemical safety evaluations. Key developments shaping this period involve the incorporation of multi-omics datasets to enhance toxicity forecasts, the creation of in silico models for drug toxicity assessments, the use of high-throughput screening techniques for toxicological purposes, the improved prioritization of chemicals through artificial intelligence, and the deployment of cloud-based systems for managing toxicology data.
Download A Free Sample Report For Comprehensive Market Insights:
Artificial Intelligence (AI) In Predictive Toxicology Market Opportunity Drivers: What Is Creating New Revenue Potential?
The growing need for faster and more ethical approaches to drug discovery is anticipated to boost the expansion of the artificial intelligence (AI) in predictive toxicology market moving forward. Drug discovery is a complex and dynamic process involving the methodical investigation, synthesis, and assessment of chemical compounds aimed at identifying promising therapeutic agents to treat diseases and improve human health, while efficient and ethical drug discovery processes integrate advanced technologies and prioritize responsible research practices in the creation of new treatments. This demand is fueled by the rise in chronic illnesses, the increasing shift toward personalized medicine, and a higher occurrence of age-related conditions. Artificial intelligence in predictive toxicology streamlines drug development by rapidly processing extensive datasets to forecast potential toxic effects, thus accelerating the timeline and upholding ethical considerations. For example, data from the Office for National Statistics, a UK government body, revealed that in 2023, the UK’s net research and development spending reached £17.4 billion ($22.1 billion), up from £16.1 billion ($20.45 billion) in 2022, representing an 8.2% increase. Consequently, the rising emphasis on efficient and ethical drug discovery is propelling the growth of the artificial intelligence in predictive toxicology market.
Artificial Intelligence (AI) In Predictive Toxicology Market Segment Analysis Highlighting Growth Areas
The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –
1) By Component: Solution, Services
2) By Technology: Machine Learning, Other Technologies
3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints
4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users
Subsegments:
1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems
2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services
Artificial Intelligence (AI) In Predictive Toxicology Market Innovation Trends Driving Future Development
Leading players in the artificial intelligence (AI)-driven predictive toxicology sector are increasingly turning to strategic partnerships as a means to strengthen their market position and drive innovation. By combining AI and machine learning techniques, these collaborations aim to refine the ways in which toxicity is predicted and assessed for chemical compounds and pharmaceuticals. A concrete example comes from January 2024, when SyntheticGestalt, a UK-based AI research company focused on drug discovery, joined forces with Enamine, a Ukrainian supplier of chemical building blocks, screening compounds, and integrated drug discovery services. The partnership’s goal was to develop a suite of AI models that support the generation of synthetically accessible, biologically active molecules while optimizing their physicochemical and ADME/Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) characteristics. These models are slated for use in SyntheticGestalt’s compound discovery initiatives, serving both academic researchers and pharmaceutical firms through their service offerings. In a key move, Enamine granted access to its immense REAL database, which holds 38 billion molecules. SyntheticGestalt plans to incorporate this resource into its Drug Discovery Service, relying on proprietary AI models to forecast compounds’ physicochemical and ADME/Tox profiles. When problematic compounds are identified, the service will rapidly propose enhanced alternatives.
Artificial Intelligence (AI) In Predictive Toxicology Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the artificial intelligence (ai) in predictive toxicology market are Certara Inc, Schrödinger Inc, Instem plc, Simulations Plus Inc, Lhasa Limited, Chemaxon Ltd, Algorithme Pharma, Benevolent AI, Berg Health, Biovista Inc, Recursion Pharmaceuticals Inc, Exscientia plc, Insilico Medicine Inc, Celsius Therapeutics Inc, ArisGlobal, Merative L.P., BioTeam Inc, Leadscope Inc, MultiCASE Inc, ACD Labs, Optibrium Ltd, Chemotargets SL, Toxys BV
Access The Complete Artificial Intelligence (AI) In Predictive Toxicology Market Report:
Artificial Intelligence (AI) In Predictive Toxicology Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in predictive toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
